A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

The use of a smart speaker with preprogrammed diabetes care features may help older adults manage their diabetes and improve ...

A 5-day fasting-mimicking diet can help improve blood sugar control in type 2 diabetes, according to a recent clinical trial.

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85th ...

Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...